Daniel C Lazar (Daniel Lazar)

Publication Activity (10 Years)

Years Active: 2019-2020
Publications (10 Years): 3

Top Topics

Dendritic Cells

Pseudomonas Aeruginosa

Top Venues

Science (New York, N.Y.)

Journal of immunology (Baltimore, Md. : 1950)

Science immunology

This page only lists publications with an associated author ORCID identifier.

Publications

Emily N Chin, Chenguang Yu, Vincent F Vartabedian, Ying Jia, Manoj Kumar, Ana M Gamo, William Vernier, Sabrina H Ali, Mildred Kissai, Daniel C Lazar, Nhan Nguyen, Laura E Pereira, Brent Benish, Ashley K Woods, Sean B Joseph, Alan Chu, Kristen A Johnson, Philipp N Sander, Francisco Martínez-Peña, Eric N Hampton, Travis S Young, Dennis W Wolan, Arnab K Chatterjee, Peter G Schultz, H Michael Petrassi, John R Teijaro, Luke L Lairson
Antitumor activity of a systemic STING-activating non-nucleotide cGAMP mimetic. Science (New York, N.Y.) 369 (6506) (2020)
Balyn W Zaro, Ekaterina V Vinogradova, Daniel C Lazar, Megan M Blewett, Radu M Suciu, Junichiro Takaya, Sean Studer, Juan Carlos de la Torre, Jean-Laurent Casanova, Benjamin F Cravatt, John R Teijaro
Dimethyl Fumarate Disrupts Human Innate Immune Signaling by Targeting the IRAK4-MyD88 Complex. Journal of immunology (Baltimore, Md. : 1950) 202 (9) (2019)
Namir Shaabani, Nadine Honke, Nhan Nguyen, Zhe Huang, Kei-Ichiro Arimoto, Daniel C Lazar, Taylor K Loe, Karl S Lang, Marco Prinz, Klaus-Peter Knobeloch, Dong-Er Zhang, John R Teijaro
The probacterial effect of type I interferon signaling requires its own negative regulator USP18. Science immunology 3 (27) (2019)